HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sten Fredrikson Selected Research
Sten Fredrikson Research Topics
Disease
15
Multiple Sclerosis
01/2023 - 09/2003
5
Relapsing-Remitting Multiple Sclerosis
01/2017 - 02/2009
2
Infections
03/2022 - 11/2003
2
Chronic Progressive Multiple Sclerosis
04/2013 - 01/2012
1
Alzheimer Disease (Alzheimer's Disease)
03/2022
1
Human Influenza (Influenza)
03/2022
1
Parkinson Disease (Parkinson's Disease)
03/2022
1
Fatigue
11/2010
1
Polyneuropathies (Polyneuropathy)
08/2008
1
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
08/2008
1
Optic Neuritis (Retrobulbar Neuritis)
03/2002
Drug/Important Bio-Agent (IBA)
5
Interferons
IBA
04/2013 - 09/2003
5
Interferon-beta
IBA
01/2012 - 09/2003
2
Antigens
IBA
03/2022 - 03/2002
2
Interferon beta-1a
FDA Link
01/2019 - 09/2003
2
Interferon beta-1b (Betaseron)
FDA Link
05/2012 - 09/2003
2
Glatiramer Acetate (Copaxone)
FDA Link
11/2010 - 02/2009
1
Gadolinium
IBA
01/2023
1
Amantadine (Aman)
FDA Link
Generic
03/2022
1
Viral Antigens
IBA
03/2022
1
Antiviral Agents (Antivirals)
IBA
03/2022
1
Dopamine (Intropin)
FDA Link
Generic
03/2022
1
Formaldehyde (Formol)
FDA Link
03/2022
1
Capsid Proteins (Capsid Protein)
IBA
03/2022
1
Protons (Proton)
IBA
01/2020
1
Alemtuzumab (Campath)
FDA Link
01/2017
1
Biomarkers (Surrogate Marker)
IBA
11/2015
1
Histocompatibility Antigens (Histocompatibility Antigen)
IBA
02/2013
1
Natalizumab (Tysabri)
FDA Link
01/2013
1
Fingolimod Hydrochloride (FTY720)
FDA Link
01/2013
1
Type I Tumor Necrosis Factor Receptors
IBA
08/2008
1
Intravenous Immunoglobulins (IVIG)
FDA Link
08/2008
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
08/2008
1
Type II Tumor Necrosis Factor Receptors
IBA
08/2008
1
Steroids
IBA
11/2003
1
Debrisoquin (Debrisoquine)
IBA
09/2003
1
Cytochrome P-450 CYP2C19
IBA
09/2003
1
Mephenytoin (Mesantoin)
FDA Link
09/2003
1
Cytochrome P-450 CYP2D6 (CYP2D6)
IBA
09/2003
1
Immunoglobulin M (IgM)
IBA
03/2002
1
Immunoglobulin G (IgG)
IBA
03/2002
Therapy/Procedure
3
Therapeutics
01/2017 - 01/2012
2
Immunomodulation
11/2010 - 02/2009
1
Stem Cell Transplantation
10/2014
1
Complementary Therapies (Alternative Medicine)
07/2013
1
Treatment Delay
05/2012
1
Aftercare (After-Treatment)
08/2008